220 related articles for article (PubMed ID: 31090018)
21. A cost-utility analysis for catheter ablation of atrial fibrillation in combination with warfarin and dabigatran based on the CHADS
Kimura T; Igarashi A; Ikeda S; Nakajima K; Kashimura S; Kunitomi A; Katsumata Y; Nishiyama T; Nishiyama N; Fukumoto K; Tanimoto Y; Aizawa Y; Fukuda K; Takatsuki S
J Cardiol; 2017 Jan; 69(1):89-97. PubMed ID: 26947099
[TBL] [Abstract][Full Text] [Related]
22. Radiofrequency catheter ablation and antiarrhythmic drug therapy: a prospective, randomized, 4-year follow-up trial: the APAF study.
Pappone C; Vicedomini G; Augello G; Manguso F; Saviano M; Baldi M; Petretta A; Giannelli L; Calovic Z; Guluta V; Tavazzi L; Santinelli V
Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):808-14. PubMed ID: 21946315
[TBL] [Abstract][Full Text] [Related]
23. Bayesian network meta-analysis comparing cryoablation, radiofrequency ablation, and antiarrhythmic drugs as initial therapies for atrial fibrillation.
Elsayed M; Abdelfattah OM; Sayed A; Prasad RM; Barakat AF; Elgendy IY; Andrade J; Jared Bunch T; Thosani A; Saliba WI; Wazni OM; Hussein AA
J Cardiovasc Electrophysiol; 2022 Feb; 33(2):197-208. PubMed ID: 34855270
[TBL] [Abstract][Full Text] [Related]
24. Cost comparison of ablation versus antiarrhythmic drugs as first-line therapy for atrial fibrillation: an economic evaluation of the RAAFT pilot study.
Khaykin Y; Wang X; Natale A; Wazni OM; Skanes AC; Humphries KH; Kerr CR; Verma A; Morillo CA
J Cardiovasc Electrophysiol; 2009 Jan; 20(1):7-12. PubMed ID: 18803564
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness of cryoballoon ablation for the management of paroxysmal atrial fibrillation.
Reynolds MR; Lamotte M; Todd D; Khaykin Y; Eggington S; Tsintzos S; Klein G
Europace; 2014 May; 16(5):652-9. PubMed ID: 24390386
[TBL] [Abstract][Full Text] [Related]
26. Prediction of long-term outcomes of catheter ablation of persistent atrial fibrillation by parameters of preablation DC cardioversion.
Kang JH; Lee DI; Kim S; Kim MN; Park YM; Ban JE; Choi JI; Lim HE; Park SW; Kim YH
J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1165-70. PubMed ID: 22882453
[TBL] [Abstract][Full Text] [Related]
27. Cost-Effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy in Atrial Fibrillation: The CABANA Randomized Clinical Trial.
Chew DS; Li Y; Cowper PA; Anstrom KJ; Piccini JP; Poole JE; Daniels MR; Monahan KH; Davidson-Ray L; Bahnson TD; Al-Khalidi HR; Lee KL; Packer DL; Mark DB;
Circulation; 2022 Aug; 146(7):535-547. PubMed ID: 35726631
[TBL] [Abstract][Full Text] [Related]
28. Usefulness and safety of transcatheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy.
Gaita F; Di Donna P; Olivotto I; Scaglione M; Ferrero I; Montefusco A; Caponi D; Conte MR; Nistri S; Cecchi F
Am J Cardiol; 2007 Jun; 99(11):1575-81. PubMed ID: 17531584
[TBL] [Abstract][Full Text] [Related]
29. Minimal energy requirement for external cardioversion and catheter ablation for long-standing persistent atrial fibrillation.
Kim IS; Kim TH; Yang PS; Uhm JS; Joung B; Lee MH; Pak HN
J Cardiol; 2017 Jan; 69(1):162-168. PubMed ID: 26987790
[TBL] [Abstract][Full Text] [Related]
30. Administration of antiarrhythmic drugs to maintain sinus rhythm after catheter ablation for atrial fibrillation: a meta-analysis.
Xu X; Alida CT; Yu B
Cardiovasc Ther; 2015 Aug; 33(4):242-6. PubMed ID: 26031448
[TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness of cardioversion and antiarrhythmic therapy in nonvalvular atrial fibrillation.
Catherwood E; Fitzpatrick WD; Greenberg ML; Holzberger PT; Malenka DJ; Gerling BR; Birkmeyer JD
Ann Intern Med; 1999 Apr; 130(8):625-36. PubMed ID: 10215558
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of combined catheter ablation and left atrial appendage closure for symptomatic atrial fibrillation in patients with high stroke and bleeding risk.
Kawakami H; Nolan MT; Phillips K; Scuffham PA; Marwick TH
Am Heart J; 2021 Jan; 231():110-120. PubMed ID: 32822655
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of radiofrequency catheter ablation compared with antiarrhythmic drug therapy for paroxysmal atrial fibrillation.
Reynolds MR; Zimetbaum P; Josephson ME; Ellis E; Danilov T; Cohen DJ
Circ Arrhythm Electrophysiol; 2009 Aug; 2(4):362-9. PubMed ID: 19808491
[TBL] [Abstract][Full Text] [Related]
34. Catheter ablation vs. antiarrhythmic drugs as 'first-line' initial therapy for atrial fibrillation: a pooled analysis of randomized data.
Chen S; Pürerfellner H; Ouyang F; Kiuchi MG; Meyer C; Martinek M; Futyma P; Zhu L; Schratter A; Wang J; Acou WJ; Ling Z; Yin Y; Liu S; Sommer P; Schmidt B; Chun JKR
Europace; 2021 Dec; 23(12):1950-1960. PubMed ID: 34405878
[TBL] [Abstract][Full Text] [Related]
35. Role of insertable cardiac monitors in anticoagulation therapy in patients with atrial fibrillation at high risk of bleeding.
Mascarenhas DA; Farooq MU; Ziegler PD; Kantharia BK
Europace; 2016 Jun; 18(6):799-806. PubMed ID: 26614520
[TBL] [Abstract][Full Text] [Related]
36. Comparison of rate control versus rhythm control for management of atrial fibrillation in patients with coexisting heart failure: a cost-effectiveness analysis.
Perez A; Touchette DR; DiDomenico RJ; Stamos TD; Walton SM
Pharmacotherapy; 2011 Jun; 31(6):552-65. PubMed ID: 21923439
[TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
Freeman JV; Zhu RP; Owens DK; Garber AM; Hutton DW; Go AS; Wang PJ; Turakhia MP
Ann Intern Med; 2011 Jan; 154(1):1-11. PubMed ID: 21041570
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of catheter ablation versus medical therapy for the treatment of atrial fibrillation in the United Kingdom.
Leung LWM; Imhoff RJ; Marshall HJ; Frame D; Mallow PJ; Goldstein L; Wei T; Velleca M; Taylor H; Gallagher MM
J Cardiovasc Electrophysiol; 2022 Feb; 33(2):164-175. PubMed ID: 34897897
[TBL] [Abstract][Full Text] [Related]
39. Point-by-Point Radiofrequency Ablation Versus the Cryoballoon or a Novel Combined Approach: A Randomized Trial Comparing 3 Methods of Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation (The Cryo Versus RF Trial).
Hunter RJ; Baker V; Finlay MC; Duncan ER; Lovell MJ; Tayebjee MH; Ullah W; Siddiqui MS; McLEAN A; Richmond L; Kirkby C; Ginks MR; Dhinoja M; Sporton S; Earley MJ; Schilling RJ
J Cardiovasc Electrophysiol; 2015 Dec; 26(12):1307-14. PubMed ID: 26727045
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the effect of prior antiarrhythmic drug use on the success of atrial fibrillation catheter ablation.
Wang M; Tellor KB; Ramaswamy K; Krainik AJ; Armbruster AL
J Clin Pharm Ther; 2019 Oct; 44(5):708-714. PubMed ID: 31056776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
